Century Therapeutics, Inc. (IPSC) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$103.88M | +5.7% |
| 2024 | -$110.14M | -24.7% |
| 2023 | -$88.35M | -728.7% |
| 2022 | $14.05M | +115.8% |
| 2021 | -$89.00M | -115.7% |
| 2020 | -$41.27M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$103.88M | +5.7% |
| 2024 | -$110.14M | -24.7% |
| 2023 | -$88.35M | -728.7% |
| 2022 | $14.05M | +115.8% |
| 2021 | -$89.00M | -115.7% |
| 2020 | -$41.27M | — |